These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28085286)

  • 1. Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.
    Tso SC; Lou M; Wu CY; Gui WJ; Chuang JL; Morlock LK; Williams NS; Wynn RM; Qi X; Chuang DT
    J Med Chem; 2017 Feb; 60(3):1142-1150. PubMed ID: 28085286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
    Tso SC; Qi X; Gui WJ; Wu CY; Chuang JL; Wernstedt-Asterholm I; Morlock LK; Owens KR; Scherer PE; Williams NS; Tambar UK; Wynn RM; Chuang DT
    J Biol Chem; 2014 Feb; 289(7):4432-43. PubMed ID: 24356970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
    Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
    Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
    Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
    J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global view of cognate kinase activation by the human pyruvate dehydrogenase complex.
    Guevara EL; Yang L; Birkaya B; Zhou J; Nemeria NS; Patel MS; Jordan F
    Sci Rep; 2017 Feb; 7():42760. PubMed ID: 28230160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
    Zhou X; Yu S; Su J; Sun L
    Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse mechanisms of inhibition of pyruvate dehydrogenase kinase by structurally distinct inhibitors.
    Mann WR; Dragland CJ; Vinluan CC; Vedananda TR; Bell PA; Aicher TD
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):283-92. PubMed ID: 11004568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
    Korotchkina LG; Sidhu S; Patel MS
    Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.
    Kato M; Li J; Chuang JL; Chuang DT
    Structure; 2007 Aug; 15(8):992-1004. PubMed ID: 17683942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells.
    Moore JD; Staniszewska A; Shaw T; D'Alessandro J; Davis B; Surgenor A; Baker L; Matassova N; Murray J; Macias A; Brough P; Wood M; Mahon PC
    Oncotarget; 2014 Dec; 5(24):12862-76. PubMed ID: 25404640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
    Li J; Kato M; Chuang DT
    J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
    Holness MJ; Bulmer K; Smith ND; Sugden MC
    Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.
    Tuganova A; Boulatnikov I; Popov KM
    Biochem J; 2002 Aug; 366(Pt 1):129-36. PubMed ID: 11978179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.
    Jeoung NH
    Diabetes Metab J; 2015 Jun; 39(3):188-97. PubMed ID: 26124988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds.
    Kang J; Pagire HS; Kang D; Song YH; Lee IK; Lee KT; Park CJ; Ahn JH; Kim J
    Biochem Biophys Res Commun; 2020 Jun; 527(3):778-784. PubMed ID: 32444142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
    Bao H; Kasten SA; Yan X; Roche TE
    Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4.
    Kukimoto-Niino M; Tokmakov A; Terada T; Ohbayashi N; Fujimoto T; Gomi S; Shiromizu I; Kawamoto M; Matsusue T; Shirouzu M; Yokoyama S
    Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):763-73. PubMed ID: 21904029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
    Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
    Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
    Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.